Program Description

The objective is to promote collaborations between academic, clinical, and industrial entities to test and demonstrate innovative solutions for effective and personalized treatment of patients with multiple chronic diseases.

Research will focus on the use of multimodal data for diagnosis, monitoring, and treatment, including remote monitoring, decision-support tools, and improving adherence to long-term therapies.

Projects must be tested in controlled real-world environments (such as hospitals, community clinics, or virtual settings), with a clear strategy for data collection, processing, and use. 

Finance

The Innovation Authority grant rate will be 66% of the approved budget for industrial corporations and 80% of the approved budget for commercialization companies (academia). The total grant budget allocated by the Innovation Authority for all Israeli participants approved under the EP PerMed RITC sub-program in 2026 is €0.5 million.  

This does not constitute a commitment to pay this amount, in whole or in part.  

Participants funded by the Ministry of Health under its public call will not be eligible for double funding from both the Innovation Authority and the Ministry of Health for the same activity, subject to the ISERD Procedure. 

Criteria

• The call is open to Israeli Industrial corporations that submitted an application to the EP PerMed sub-program and researchers from Israeli academia through the research institution’s commercialization company, conducting joint research with an Israeli industrial corporation partner in the consortium, which committed to fund at least 10% of the Israeli academic partner’s project budget). 

• According to sub-program rules, submission within an international consortium under EP PerMed requires at least three partners from at least three different participating countries, with at least one being an EU member state. 

Application Process

Submission deadlines are as follows: 

EP PerMed Partnership: 

• Stage 1 deadline: January 12, 2026, 14:00 CET 

• Stage 2 deadline: April 27, 2026, 14:00 CET Deadlines are set by EP PerMed management and may change. Applicants must verify dates and conditions on the official website.  

Israel Innovation Authority: 

• Stage 1 deadline: January 19, 2026, 12:00 Israel time 

• Stage 2 deadline: May 3, 2026, 12:00 Israel time Submission is via the Innovation Authority personal area. 

Note: 

The Innovation Authority reserves the sole discretion to change any of the dates listed in this call for proposals, by a notice to be published on the Authority’s website – on the call for proposals page, including postponing any of the dates, as long as it has not yet passed.  

It is the responsibility of the proposers to update from time to time the Innovation Authority’s website, regarding date postponements, or updates, changes, notices, or clarifications that will be in connection with the competitive process.